SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 184 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $65 | -99.9% | 50,000 | +316.7% | 0.00% | 0.0% |
Q3 2022 | $59,000 | -96.2% | 12,000 | -87.9% | 0.00% | -96.2% |
Q4 2020 | $1,545,000 | +194.3% | 99,030 | +258.2% | 0.10% | +118.8% |
Q1 2018 | $525,000 | +27.4% | 27,650 | +10.0% | 0.05% | +23.1% |
Q4 2017 | $412,000 | -40.5% | 25,140 | -45.6% | 0.04% | -45.8% |
Q3 2017 | $693,000 | +118.6% | 46,200 | +28.4% | 0.07% | +100.0% |
Q2 2017 | $317,000 | – | 35,990 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
EMC Capital Management | 48,992 | $765,000 | 0.58% |
Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |